Background: Metastatic breast cancer (MBC) is incurable, despite recent therapeutic advances resulting in extended trajectories of disease, especially in estrogen receptor positive (ER+) and human epidermal growth factor-2 negative (HER2-) MBC....
Background: Despite improvements, patients with advanced cancer often do not receive goal-concordant care at the end of life (EOL). Challenges with prognostication contribute to delays ACP conversations and result in more aggressive care, gaps in...